Harrow Health Company Insiders
HROW Stock | USD 43.88 1.44 3.39% |
Harrow Health's insiders are aggressively buying. The analysis of insiders' sentiment of trading Harrow Health stock suggests that vertually all insiders are extremely bullish at this time. Harrow Health employs about 315 people. The company is managed by 14 executives with a total tenure of roughly 735 years, averaging almost 52.0 years of service per executive, having 22.5 employees per reported executive.
Harrow Health's Insider Buying Vs Selling
100
Selling | Buying |
Latest Trades
2024-04-25 | Opaleye Management Inc. | Acquired 20000 @ 9.97 | View | ||
2024-04-23 | Opaleye Management Inc. | Acquired 11715 @ 10.29 | View | ||
2024-04-19 | Opaleye Management Inc. | Acquired 29400 @ 10.56 | View | ||
2024-03-28 | Opaleye Management Inc. | Acquired 50000 @ 12.82 | View | ||
2024-03-22 | Mark L Baum | Acquired 9000 @ 11.59 | View | ||
2024-03-20 | Opaleye Management Inc. | Acquired 50600 @ 9.65 | View |
Monitoring Harrow Health's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Harrow |
Harrow Health's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Harrow Health's future performance. Based on our forecasts, it is anticipated that Harrow will maintain a workforce of slightly above 320 employees by December 2024.Harrow Health Management Team Effectiveness
The company has return on total asset (ROA) of (0.0168) % which means that it has lost $0.0168 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5023) %, meaning that it created substantial loss on money invested by shareholders. Harrow Health's management efficiency ratios could be used to measure how well Harrow Health manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to climb to 0 in 2024, whereas Return On Tangible Assets are likely to drop (0.17) in 2024. At this time, Harrow Health's Total Assets are fairly stable compared to the past year. Total Current Assets is likely to climb to about 146 M in 2024, despite the fact that Non Currrent Assets Other are likely to grow to (2 M).Common Stock Shares Outstanding is likely to climb to about 34.2 M in 2024, despite the fact that Net Loss is likely to grow to (12 M).
Harrow Health Workforce Comparison
Harrow Health is one of the top stocks in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 827. Harrow Health totals roughly 315 in number of employees claiming about 38% of equities under Health Care industry.
Harrow Health Profit Margins
The company has Profit Margin (PM) of (0.2) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.03 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.03.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.47 | 0.6955 |
|
|
Harrow Health Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Harrow Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Harrow Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Harrow Health insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-09-01 | 0.5 | 1 | 2 | 90,000 | 135,140 |
2024-03-01 | 1.2222 | 11 | 9 | 368,638 | 343,732 |
2023-12-01 | 1.5 | 3 | 2 | 52,500 | 29,778 |
2023-09-01 | 1.1667 | 7 | 6 | 1,431,800 | 1,931,398 |
2023-06-01 | 4.0 | 8 | 2 | 1,596,976 | 297,633 |
2023-03-01 | 0.5 | 3 | 6 | 201,000 | 280,223 |
2022-09-01 | 2.0 | 2 | 1 | 11,085 | 40,000 |
2022-03-01 | 0.8333 | 5 | 6 | 231,343 | 342,934 |
2021-09-01 | 5.0 | 15 | 3 | 1,531,001 | 23,900 |
2021-06-01 | 2.0 | 10 | 5 | 1,090,660 | 1,371,461 |
2021-03-01 | 1.6667 | 5 | 3 | 455,000 | 237,500 |
2020-09-01 | 1.6667 | 10 | 6 | 355,298 | 93,798 |
2020-06-01 | 15.0 | 15 | 1 | 778,924 | 600,000 |
2020-03-01 | 0.75 | 6 | 8 | 467,718 | 457,719 |
2019-12-01 | 0.5 | 2 | 4 | 195,000 | 208,000 |
2019-06-01 | 1.3333 | 4 | 3 | 38,860 | 30,000 |
2019-03-01 | 1.6667 | 5 | 3 | 350,000 | 30,000 |
2018-03-01 | 2.5 | 5 | 2 | 310,000 | 60,000 |
2017-06-01 | 2.3333 | 7 | 3 | 317,892 | 255,000 |
2017-03-01 | 4.0 | 4 | 1 | 322,000 | 20,000 |
2016-12-01 | 4.0 | 8 | 2 | 885,000 | 283,709 |
2016-06-01 | 5.0 | 10 | 2 | 1,570,950 | 1,207,500 |
2016-03-01 | 4.0 | 4 | 1 | 150,000 | 15,000 |
2015-06-01 | 2.3333 | 7 | 3 | 78,207 | 425,282 |
2015-03-01 | 2.0 | 4 | 2 | 307,500 | 25,000 |
2014-09-01 | 2.0 | 6 | 3 | 98,367 | 90,465 |
2012-12-01 | 0.5 | 1 | 2 | 38,014 | 0.00 |
2012-09-01 | 1.0 | 7 | 7 | 6,371,623 | 15,979,883 |
2012-06-01 | 2.0 | 14 | 7 | 23,285,286 | 778,812 |
2012-03-01 | 0.6667 | 8 | 12 | 3,133,261 | 13,266,761 |
2011-12-01 | 0.25 | 1 | 4 | 493.00 | 4,928 |
2009-12-01 | 1.0 | 1 | 1 | 215,000 | 85,000 |
2008-12-01 | 5.0 | 5 | 1 | 290,000 | 10,000 |
2008-09-01 | 3.5 | 7 | 2 | 7,900 | 20,000 |
2008-06-01 | 3.0 | 3 | 1 | 304,200 | 300,000 |
Harrow Health Notable Stakeholders
A Harrow Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Harrow Health often face trade-offs trying to please all of them. Harrow Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Harrow Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
CMA CFA | CFO Secretary | Profile | |
Robert DDS | Special Advisor | Profile | |
Jamie Webb | Director Relations | Profile | |
David Moufarrge | VP Technology | Profile | |
RPh Mannebach | Head Pharmacovigilance | Profile | |
Brett Burrell | Vice Compliance | Profile | |
CFA CMA | CFO Sec | Profile | |
Andrew Livingston | Chief Officer | Profile | |
Larry MD | Chief Officer | Profile | |
Mark JD | CEO Chairman | Profile | |
Kim Barratt | Chief Officer | Profile | |
Greg DiPasquale | Senior Commercial | Profile | |
John MBA | Chief Officer | Profile | |
Dennis PharmD | Chief Strategy | Profile |
About Harrow Health Management Performance
The success or failure of an entity such as Harrow Health often depends on how effective the management is. Harrow Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Harrow management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Harrow management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.16) | (0.17) | |
Return On Assets | (0.08) | (0.08) | |
Return On Equity | (0.35) | (0.36) |
Please note, the imprecision that can be found in Harrow Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Harrow Health. Check Harrow Health's Beneish M Score to see the likelihood of Harrow Health's management manipulating its earnings.
Harrow Health Workforce Analysis
Traditionally, organizations such as Harrow Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Harrow Health within its industry.Harrow Health Manpower Efficiency
Return on Harrow Health Manpower
Revenue Per Employee | 413.3K | |
Revenue Per Executive | 9.3M | |
Net Loss Per Employee | 77.5K | |
Net Loss Per Executive | 1.7M | |
Working Capital Per Employee | 286.2K | |
Working Capital Per Executive | 6.4M |
Additional Tools for Harrow Stock Analysis
When running Harrow Health's price analysis, check to measure Harrow Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harrow Health is operating at the current time. Most of Harrow Health's value examination focuses on studying past and present price action to predict the probability of Harrow Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harrow Health's price. Additionally, you may evaluate how the addition of Harrow Health to your portfolios can decrease your overall portfolio volatility.